The global apheresis market was valued at $2.4 billion in 2021 and is projected to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.

Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.

Apheresis is the process of removing blood from a patient while using a special machine to separate the different components of blood. One or more components are removed to use in treatments or ...